Basit öğe kaydını göster

dc.contributor.authorSayın Şakul, Arzu
dc.contributor.authorArı, Nuray
dc.contributor.authorSotnikova, Ruzenna
dc.contributor.authorOzansoy, Gülgün
dc.contributor.authorKarasu, Çimen
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:50:21Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T19:50:21Z
dc.date.issued2018en_US
dc.identifier.citationSayın Şakul, A., Arı, N., Sotnikova, R., Ozansoy, G. ve Karasu, Ç. (2018). A pyridoindole antioxidant SMe1EC2 regulates contractility, relaxation ability, cation channel activity, and protein-carbonyl modifications in the aorta of young and old rats with or without diabetes mellitus. Geroscience, 40(4), 377-392. https://dx.doi.org/10.1007/s11357-018-0034-yen_US
dc.identifier.issn2509-2715
dc.identifier.issn2509-2723
dc.identifier.urihttps://dx.doi.org/10.1007/s11357-018-0034-y
dc.identifier.urihttps://hdl.handle.net/20.500.12511/1959
dc.descriptionWOS: 000444557200004en_US
dc.descriptionPubMed ID: 30054861en_US
dc.description.abstractWe studied the effects of treatment with SMe1EC, a hexahydropyridoindole antioxidant, on vascular reactivity, endothelial function, and oxidonitrosative stress level of thoracic aorta in young and old rats with or without diabetes mellitus. The rats were grouped as young control (YC 3 months old), old control (OC 15 months old), young diabetic (YD), old diabetic (OD), young control treated (YCT), old control treated (OCT), young diabetic treated (YDT), and old diabetic treated (ODT). Diabetes was induced by streptozotocin injection and subsequently SMe1EC2 (10 mg/kg/day, p.o.) was administered to YCT, OCT, YDT, and ODT rats for 5 months. In young and old rats, diabetes resulted in hypertension, weight loss, hyperglycemia, and hypertriglyceridemia, which were partially prevented by SMe1EC2. SMe1EC2 also inhibited the diabetes-induced increase in aorta levels of AGEs (advanced glycosylation end-protein adducts), 4-HNE (4-hydroxy-nonenal-histidine), 3-NT (3-nitrotyrosine), and RAGEs (receptors for AGEs). The contractions of the aorta rings to phenylephrine (Phe) and KCL did not significantly change, but acetylcholine (ACh) and salbutamol relaxations were reduced in OC compared to YC rats. Diabetes induction increased Phe contractions in YC and OC rats, KCL contractions in YC rats, and did not cause further inhibition in already inhibited ACh and salbutamol relaxations in OC rats. We have achieved the lowest levels of ACh relaxation in YD rats compared to other groups. SMe1EC2 did not change the response of aorta to ACh, salbutamol and Phe in YC rats, and ameliorated ACh relaxations in OC and YD but not in OD rats. In YDT and ODT rats, increased Phe and KCL contractions, high blood pressure, and impaired salbutamol relaxations were amended by SMe1EC2. Phe contractions observed in YD and OD rats as well as KCl contractions observed in OC rats were the lowest levels when the rats were treated with SMe1EC2. When the bath solution was shifted to cyclopiazonic acid (CYP) or CYP plus Ca2+-free medium, the contraction induced by a single dose of Phe (3 x 10(-6) M) was more inhibited in YD and OD than in YC but not in OC rats. In SMe1EC2-treated rats, neither the presence of CFM nor CFM plus CYP exhibited a significant change in response of aorta to a single dose of Phe. These findings suggest that alpha 1-adrenergic receptor signaling is activated in both age groups of diabetic rats, diabetes activates K+-depolarization and calcium mobilization via Ca-V especially in the aorta of young rats, and sensitizes the aorta of old rats to the regulating effect of SMe1EC2. ACh relaxations were inhibited in YC rats, increased in OC rats and unchanged in YD and OD rats when aortic rings pretreated with TEA, an inhibitor of calcium-activated K+ channels (K-Ca), or 4-aminopyridine (4-AP), an inhibitor of voltage-sensitive K+ channels (K-V). ACh relaxations were inhibited in YCT, OCT, and YDT rats in the presence of 4-AP or TEA. In ODT rats, 4-AP did not change ACh relaxation but TEA inhibited. These findings suggest that the contribution of K-v and K-Ca to ACh relaxation is likely upregulated by SMe1EC2 when the relaxations were inhibited by aging or diabetes. We conclude that SMe1EC2 might be a promising agent for aging and diabetes related vascular disorders.en_US
dc.description.sponsorshipResearch Foundation of Gazi University [01/2010-126]; Research Foundation of Ankara University [10B336002]; COST Action [BM1203]; Slovak Academy of Sciences [APVV-51-017905]en_US
dc.description.sponsorshipThis article has been written by Prof. Karasu who is the leader of ADIC study group. We thank Ahmet Cumaolu and Elif Aydn for their technical help during measurement of some biomarkers. This work originally includes a part of the PhD thesis of Dr. Arzu Sakul and was partly supported by the Research Foundations of Gazi and Ankara Universities (GU-Project No. 01/2010-126, AU-Project No. 10B336002), COST Action BM1203 and the Slovak Academy of Sciences (VEGA grant APVV-51-017905).en_US
dc.language.isoengen_US
dc.publisherSpringeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAgingen_US
dc.subjectDiabetesen_US
dc.subjectAntioxidanten_US
dc.subjectAortaen_US
dc.subjectPyridoindoleen_US
dc.subjectRaten_US
dc.subjectProtein Carbonylationen_US
dc.subjectOxidonitrosative Stressen_US
dc.subjectContractilityen_US
dc.subjectEndotheliumen_US
dc.titleA pyridoindole antioxidant SMe1EC2 regulates contractility, relaxation ability, cation channel activity, and protein-carbonyl modifications in the aorta of young and old rats with or without diabetes mellitusen_US
dc.typearticleen_US
dc.relation.ispartofGeroscienceen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Tıbbi Farmakoloji Ana Bilim Dalıen_US
dc.authorid0000-0002-9354-0000en_US
dc.identifier.volume40en_US
dc.identifier.issue4en_US
dc.identifier.startpage377en_US
dc.identifier.endpage392en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1007/s11357-018-0034-yen_US
dc.identifier.wosqualityQ1en_US
dc.identifier.scopusqualityQ1en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster